A Case of Erythrocytosis in a Patient Treated with an Aromatase Inhibitor for Breast Cancer
A previously healthy 79-year-old female was referred to hematology for further evaluation of erythrocytosis. Two years earlier she had been diagnosed with ER/PR-positive ductal carcinoma of the breast and was receiving hormonal therapy with exemestane. No secondary cause of erythrocytosis was identi...
Main Authors: | Abhinav Iyengar, Dawn Sheppard |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2013/615189 |
Similar Items
-
Aromatase Inhibitor-Induced Erythrocytosis in a Patient Undergoing Hormonal Treatment for Breast Cancer
by: Sri Lakshmi Hyndavi Yeruva, et al.
Published: (2015-01-01) -
Effects of aromatase inhibitors on aromatase in breast
by: Vidya, Raghavan
Published: (2009) -
Management of bone loss in postmenopausal breast cancer patients treated with aromatase inhibitors
by: Margarida Maria Duarte da Silva Cepa
Published: (2019) -
Management of bone loss in postmenopausal breast cancer patients treated with aromatase inhibitors
by: Margarida Cepa, et al.
Published: (2015-10-01) -
" Aromatase and the Pharmacogenomic Profile - Influence of CYP19A1 polymorphisms in the response of breast cancer patients treated with aromatase inhibitors".
by: Schmid, Heidi
Published: (2012)